vs
Side-by-side financial comparison of CorMedix Inc. (CRMD) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $128.6M, roughly 1.1× CorMedix Inc.). CorMedix Inc. produced more free cash flow last quarter ($92.7M vs $-7.8M).
CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
CRMD vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $128.6M | $140.7M |
| Net Profit | — | $-3.2M |
| Gross Margin | 83.4% | 41.9% |
| Operating Margin | 46.0% | -1.6% |
| Net Margin | — | -2.3% |
| Revenue YoY | — | 9.1% |
| Net Profit YoY | — | 62.1% |
| EPS (diluted) | $0.20 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $128.6M | $140.7M | ||
| Q3 25 | $104.3M | $118.8M | ||
| Q2 25 | $39.7M | $105.1M | ||
| Q1 25 | $39.1M | $104.2M | ||
| Q4 24 | — | $129.0M | ||
| Q3 24 | — | $118.6M | ||
| Q2 24 | — | $120.3M | ||
| Q1 24 | — | $120.0M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $108.6M | $-11.7M | ||
| Q2 25 | $19.8M | $-17.3M | ||
| Q1 25 | $20.6M | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | — | $-39.2M | ||
| Q2 24 | — | $27.0K | ||
| Q1 24 | — | $-50.2M |
| Q4 25 | 83.4% | 41.9% | ||
| Q3 25 | 89.3% | 42.8% | ||
| Q2 25 | 95.3% | 35.9% | ||
| Q1 25 | 95.9% | 39.4% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 34.8% |
| Q4 25 | 46.0% | -1.6% | ||
| Q3 25 | 49.2% | -10.2% | ||
| Q2 25 | 49.2% | -13.5% | ||
| Q1 25 | 51.5% | -13.9% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | — | -39.5% | ||
| Q2 24 | — | -12.1% | ||
| Q1 24 | — | -19.3% |
| Q4 25 | — | -2.3% | ||
| Q3 25 | 104.1% | -9.9% | ||
| Q2 25 | 49.9% | -16.5% | ||
| Q1 25 | 52.8% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | — | -33.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | -41.8% |
| Q4 25 | $0.20 | $0.03 | ||
| Q3 25 | $1.26 | $0.11 | ||
| Q2 25 | $0.28 | $0.16 | ||
| Q1 25 | $0.30 | $0.18 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.36 | ||
| Q2 24 | — | $0.00 | ||
| Q1 24 | — | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $148.5M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $405.3M | $-29.7M |
| Total Assets | $826.1M | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $148.5M | $24.3M | ||
| Q3 25 | $55.7M | $32.4M | ||
| Q2 25 | $190.7M | $34.2M | ||
| Q1 25 | $77.5M | $21.6M | ||
| Q4 24 | — | $29.0M | ||
| Q3 24 | — | $23.4M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | — | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $405.3M | $-29.7M | ||
| Q3 25 | $374.1M | $-26.9M | ||
| Q2 25 | $220.6M | $-15.6M | ||
| Q1 25 | $114.9M | $1.3M | ||
| Q4 24 | — | $20.2M | ||
| Q3 24 | — | $28.0M | ||
| Q2 24 | — | $66.4M | ||
| Q1 24 | — | $65.5M |
| Q4 25 | $826.1M | $296.3M | ||
| Q3 25 | $750.9M | $302.1M | ||
| Q2 25 | $252.6M | $303.8M | ||
| Q1 25 | $149.6M | $293.8M | ||
| Q4 24 | — | $307.8M | ||
| Q3 24 | — | $309.3M | ||
| Q2 24 | — | $362.1M | ||
| Q1 24 | — | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $94.5M | $-5.8M |
| Free Cash FlowOCF − Capex | $92.7M | $-7.8M |
| FCF MarginFCF / Revenue | 72.1% | -5.5% |
| Capex IntensityCapex / Revenue | 1.3% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $172.8M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $94.5M | $-5.8M | ||
| Q3 25 | $30.9M | $-968.0K | ||
| Q2 25 | $30.0M | $-4.0M | ||
| Q1 25 | $19.7M | $-23.1M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $-8.9M | ||
| Q1 24 | — | $-16.8M |
| Q4 25 | $92.7M | $-7.8M | ||
| Q3 25 | $30.4M | $-1.8M | ||
| Q2 25 | $30.0M | $-7.0M | ||
| Q1 25 | $19.7M | $-25.3M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $101.0K | ||
| Q2 24 | — | $-11.0M | ||
| Q1 24 | — | $-19.9M |
| Q4 25 | 72.1% | -5.5% | ||
| Q3 25 | 29.1% | -1.5% | ||
| Q2 25 | 75.4% | -6.6% | ||
| Q1 25 | 50.5% | -24.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | -9.2% | ||
| Q1 24 | — | -16.5% |
| Q4 25 | 1.3% | 1.4% | ||
| Q3 25 | 0.5% | 0.7% | ||
| Q2 25 | 0.1% | 2.8% | ||
| Q1 25 | 0.0% | 2.2% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
